Dr. Annie Kwok Hung, MD

Dr. Hung practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Hung's NPI, 1730422015, was assigned on April 4, 2013. Dr. Hung graduated from Texas A&M College of Medicine - Bryan in 2013. Dr. Hung's Oregon license number on file is MD193278.

Dr. Hung's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Hung's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dr. Hung is also affiliated with Legacy Good Samaritan Medical Center. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Hung to 3 more hospitals, 1 clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hung practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hung's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hung is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Hung's licenses on file in 4 states: Oregon, California, Washington and Texas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Hung treats.

CMS data shows 707 Medicare services from Dr. Hung across 5 procedure codes in 2024, for 169 Medicare patients. Medicare paid $33,178 for them. Every service was in an office.

CMS counts 169 Medicare patients who saw Dr. Hung in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have cancer, and 67% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hung's median patient age at 72, with 78% women.

In 2024, Dr. Hung wrote 1,883 Medicare Part D claims for 299 patients. 86% of them were for generic drugs. CMS names the drug for 1,512 of them, across 40 drugs with 11 or more claims each, at $1,968,283 in total drug cost. In 2023, CMS named 1,386 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Hung for performance year 2024, reported through an alternative payment model (APM). Dr. Hung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hung as offering telehealth.

Dmand AI links 2 papers to Dr. Hung in 2015. Dr. Hung's most frequent co-authors are Jennifer Ellen Guy, MD, Caroline Marie Behler, MD, MS and Eugene Earl Lee, MD.

Dmand AI links Dr. Hung to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases. Open Payments lists research payments to Dr. Hung that name 1 trial.

CMS Open Payments shows 31 general payments to Dr. Hung from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Amgen Inc. paid the most, $643. It also lists 2 research payments totaling $7,172 from 2023 to 2024, naming 1 clinical trial.

Dr. Hung graduated from Texas A&M College of Medicine - Bryan in 2013.

Dr. Hung is in network with 11 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.